Drug recall · July 10, 2019
Esterified Estrogens & Methyltestosterone Tablets recall
Why: Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Esterified Estrogens & Methyltestosterone Tablets, USP 1.25 mg/2.5 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-172-01
- Lots / codes
Lot #: HL06015, HL06115, Exp. 10/2017
- Quantity
- 19176 units
- Company
- Amneal Pharmaceuticals, Inc., Brookhaven, NY
- Distribution
- Nationwide within the United States
- Initiated
- September 25, 2017 · Voluntary: Firm initiated
- Classified
- July 1, 2019
- Reported
- July 10, 2019
- Ended
- August 8, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methyltestosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.